“Brand-name medicines’ market exclusivity periods have climbed an average of 2.2 years since the mid-1990s, steadily delaying the market arrival of generic rivals. Reversing that trend alone could save the U.S. health care system roughly $31.7 billion, according to a Matrix report commissioned by the Coalition for Affordable Prescription Drugs, a group of insurers, pharmacy benefit managers and large employers.”
DetailsToday, Brill discusses President Trump’s potential appointment options for the Federal Reserve Board of Governors.
DetailsRecently, several physicians and health policy analysts took to the Health Affairs blog to propose what was, to anyone who has been following biosimilars for the last decade or more, a surprising and concerning idea: that biosimilars should be abandoned.
DetailsA Giving USA report released last week shows that US households’ charitable donations in 2018 experienced the largest decline since the Great Recession. We hate to say we told you so, but we told you so.
DetailsWatch Brill’s latest news clip from his CNBC interview where he discusses raising tax rates on the rich.
Details“He (Alex Brill) found that 10 states — many of them with large rural populations — broke records in 2019 by hitting their lowest unemployment rates in history: Alabama, Iowa, Kentucky, Mississippi, North Dakota, Pennsylvania, South Carolina, Tennessee, Vermont and Wisconsin.”
Details“Matrix Global Advisors pointed out where the focus on fighting opioids needs to be. Approximately 36 percent of people that are misusing painkillers get their drugs from doctors.”
DetailsThis week, two healthcare publications referenced MGA’s recent report concerning the HHS OIG proposed rule to restrict drug manufacturer rebates to pharmacy benefit managers (PBMs).
DetailsThis MGA analysis details concerns with a proposed rule from the Health and Human Services Office of Inspector General that would restrict drug manufacturer rebates to pharmacy benefit managers in Medicare Part D and Medicaid Managed Care Organizations. Not only does the propose rule lack evidence, but it is poorly targeted to achieve its stated goals. I
DetailsThe fourth quarter economic reports show less growth than expected. Brill shares his opinion that “things are slowing a little bit around the world and its a little bit of a timing effect between the seasonal issues that we know and the shutdown issues as well.”
Details
